446 related articles for article (PubMed ID: 15998949)
1. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.
Hance KW; Anderson WF; Devesa SS; Young HA; Levine PH
J Natl Cancer Inst; 2005 Jul; 97(13):966-75. PubMed ID: 15998949
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
Anderson WF; Chu KC; Chang S
J Clin Oncol; 2003 Jun; 21(12):2254-9. PubMed ID: 12805323
[TBL] [Abstract][Full Text] [Related]
3. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
Il'yasova D; Siamakpour-Reihani S; Akushevich I; Akushevich L; Spector N; Schildkraut J
Breast Cancer Res Treat; 2011 Nov; 130(2):691-7. PubMed ID: 21850396
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.
Chang S; Parker SL; Pham T; Buzdar AU; Hursting SD
Cancer; 1998 Jun; 82(12):2366-72. PubMed ID: 9635529
[TBL] [Abstract][Full Text] [Related]
5. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
Cancer; 2011 May; 117(9):1819-26. PubMed ID: 21509759
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.
Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K
Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049
[TBL] [Abstract][Full Text] [Related]
7. Recent trends in breast cancer among younger women in the United States.
Brinton LA; Sherman ME; Carreon JD; Anderson WF
J Natl Cancer Inst; 2008 Nov; 100(22):1643-8. PubMed ID: 19001605
[TBL] [Abstract][Full Text] [Related]
8. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
[TBL] [Abstract][Full Text] [Related]
9. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.
Kohler BA; Sherman RL; Howlader N; Jemal A; Ryerson AB; Henry KA; Boscoe FP; Cronin KA; Lake A; Noone AM; Henley SJ; Eheman CR; Anderson RN; Penberthy L
J Natl Cancer Inst; 2015 Jun; 107(6):djv048. PubMed ID: 25825511
[TBL] [Abstract][Full Text] [Related]
10. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV
J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826
[TBL] [Abstract][Full Text] [Related]
11. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
Hausauer AK; Keegan TH; Chang ET; Clarke CA
Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
[TBL] [Abstract][Full Text] [Related]
12. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.
Menashe I; Anderson WF; Jatoi I; Rosenberg PS
J Natl Cancer Inst; 2009 Jul; 101(14):993-1000. PubMed ID: 19584327
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.
Zell JA; Tsang WY; Taylor TH; Mehta RS; Anton-Culver H
Breast Cancer Res; 2009; 11(1):R9. PubMed ID: 19228416
[TBL] [Abstract][Full Text] [Related]
14. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
Liu Y; West R; Weber JD; Colditz GA
Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in breast carcinoma survival.
Joslyn SA; West MM
Cancer; 2000 Jan; 88(1):114-23. PubMed ID: 10618613
[TBL] [Abstract][Full Text] [Related]
16. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database.
Abraham HG; Xia Y; Mukherjee B; Merajver SD
Breast Cancer Res Treat; 2021 Jan; 185(1):229-238. PubMed ID: 33033965
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
DeSantis CE; Fedewa SA; Goding Sauer A; Kramer JL; Smith RA; Jemal A
CA Cancer J Clin; 2016; 66(1):31-42. PubMed ID: 26513636
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
Aurit SJ; Devesa SS; Soliman AS; Schairer C
Breast Cancer Res Treat; 2019 Jun; 175(3):755-764. PubMed ID: 30915662
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.
Levine PH; Portera CC; Hoffman HJ; Yang SX; Takikita M; Duong QN; Hewitt SM; Swain SM
Clin Breast Cancer; 2012 Aug; 12(4):232-9. PubMed ID: 22694825
[TBL] [Abstract][Full Text] [Related]
20. Age-related crossover in breast cancer incidence rates between black and white ethnic groups.
Anderson WF; Rosenberg PS; Menashe I; Mitani A; Pfeiffer RM
J Natl Cancer Inst; 2008 Dec; 100(24):1804-14. PubMed ID: 19066264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
